These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19935409)

  • 1. Pregabalin in the treatment of chronic migraine: an open-label study.
    Calandre EP; Garcia-Leiva JM; Rico-Villademoros F; Vilchez JS; Rodriguez-Lopez CM
    Clin Neuropharmacol; 2010; 33(1):35-9. PubMed ID: 19935409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse: an open-label prospective study.
    Rizzato B; Leone G; Misaggi G; Zivi I; Diomedi M
    Clin Neuropharmacol; 2011; 34(2):74-8. PubMed ID: 21412201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
    Arnold LM; Emir B; Murphy TK; Zeiher BG; Pauer L; Scott G; Petersel D
    Clin Ther; 2012 May; 34(5):1092-102. PubMed ID: 22503162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pregabalin on central sensitization in patients with migraine.
    Zhang N; Chen CF; Yu FY
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):277-83. PubMed ID: 25669613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
    Nelles G; Delbrück A; Schulze L; Kademann B; Bornhoevd K; Schäfer S; Schäuble B;
    Headache; 2009; 49(10):1454-65. PubMed ID: 19804392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America.
    Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R
    Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
    Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
    J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
    Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
    J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
    Silberstein SD; Blumenfeld AM; Cady RK; Turner IM; Lipton RB; Diener HC; Aurora SK; Sirimanne M; DeGryse RE; Turkel CC; Dodick DW
    J Neurol Sci; 2013 Aug; 331(1-2):48-56. PubMed ID: 23790235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.